TEAD4 overexpression suppresses thyroid cancer progression and metastasis in vitro by modulating Wnt signaling

Buyong Zhang1, Qingqing Wang, Yanting Ji

  • 1Department of Thyroid and Breast, Cangzhou Central Hospital, Cangzhou, China.

Journal of Biosciences
|December 24, 2021
PubMed

Insights

Thyroid cancer (TC) progression is suppressed by TEAD4, a gene typically acting as oncogenic. TEAD4 overexpression inhibits tumor growth and metastasis by modulating Wnt signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • TEAD4 is implicated as an oncogene in multiple cancers.
  • Its specific role and regulatory mechanisms in thyroid cancer (TC) require further elucidation.

Purpose of the Study:

  • To investigate the function and regulatory mechanisms of TEAD4 in thyroid cancer.
  • To determine if TEAD4 influences TC progression and metastasis.

Main Methods:

  • Gene expression analysis (GEPIA, qRT-PCR, Western blot) of TEAD4 and wnt3a in TC tissues and cells.
  • In vitro assays (MTT, Transwell) to assess TC cell viability, migration, and invasion following TEAD4 overexpression and Wnt signaling inhibition (IWR-1-endo).
  • Analysis of epithelial-mesenchymal transition (EMT) markers (E-cadherin, N-cadherin, Vimentin).

Main Results:

  • TEAD4 was found to be downregulated in TC tissues and cells.
  • Overexpression of TEAD4 suppressed TC cell viability, migration, and invasion.
  • TEAD4 overexpression promoted E-cadherin and wnt3a expression while downregulating N-cadherin and Vimentin.
  • TEAD4 expression positively correlated with wnt3a expression.
  • Inhibition of Wnt signaling reversed the effects of TEAD4 overexpression.

Conclusions:

  • TEAD4 acts as a tumor suppressor in thyroid cancer, contrary to its oncogenic role in other cancers.
  • TEAD4 overexpression inhibits TC progression and metastasis in vitro.
  • TEAD4 exerts its suppressive effects through the modulation of Wnt signaling.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.2K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.5K